Gencurix can diagnose breast cancer through needle biopsy before surgery

Gencurix presented the research results on GenesWell BCT, a breast cancer prognostic test, in an international journal.

GenesWell BCT is a prognostic test that makes the prognosis of other cancer metastasis and recurrence within 10 years, by analyzing the expression levels of six cancer prognostic genes and three standard genes extracted from the RNA of cancer tissues removed during surgery of breast cancer patients.

The study, led by Kyungpook National University Hospital, compared the accuracy of GenesWell BCT test for tissue samples obtained with a core needle biopsy and post-operative tissue specimens for preoperative diagnosis of breast cancer patients

More information

Details

Korea

Korea Biomedical Review

Associated Trend items

GENCURIX Website Renewal

Please visit our newly designed website!

We are very pleased and excited to announce the "opening" of a totally redesigned websites for GENCURIX and GenesWell BCT. Gencurix corporate website is to provide a comprehensive information of the company and GenesWell BCT website is dedicated in highlighting its characteristics, clinical information and test process. Both websites will continuously evolve and new...

More information

Working together, South Koreans turn COVID-19 hot zone into containment leader

Gencurix is to supply its COVID-19 test worldwide

South Korea has transformed from a COVID-19 hot zone to a leader in the global fight against the virus. Companies there are now making millions of test kits for export, and the public is voting in a parliamentary election despite the disease. Special correspondent Bruce Harrison reports from Seoul on how South Koreans have worked together to make progress -- and aim to p...

More information

Gencurix Publishes a Clinical Validation Study on GenesWell BCT, a New Breast Cancer Prognostic Test

Gencurix announced that the results of clinical trials for the prediction of breast cancer prognosis were published in Scientific Reports, which is affiliated with the prestigious journal, Nature.

Gencurix, GenesWell BCT, Breast Cancer, Prognostic Test, Prognostic Multigene Test, FFPE

More information

Products associated

breast cancer test kit

GenesWell BCT

Compare

Remove all

Compare up to 10 products